Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Kidney, Polycystic

1-methyl-3-isobutylxanthine has been researched along with Kidney, Polycystic in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research Excerpts

ExcerptRelevanceReference
"Polycystic kidney disease is characterized by abnormal morphological development."1.31Distinctive cyclic AMP-dependent protein kinase subunit localization is associated with cyst formation and loss of tubulogenic capacity in Madin-Darby canine kidney cell clones. ( Marfella-Scivittaro, C; Orellana, SA, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Orellana, SA1
Marfella-Scivittaro, C1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Kidney, Polycystic

ArticleYear
Distinctive cyclic AMP-dependent protein kinase subunit localization is associated with cyst formation and loss of tubulogenic capacity in Madin-Darby canine kidney cell clones.
    The Journal of biological chemistry, 2000, Jul-14, Volume: 275, Issue:28

    Topics: 1-Methyl-3-isobutylxanthine; Alprostadil; Animals; Clone Cells; Colforsin; Cyclic AMP; Cyclic AMP-De

2000